187 related articles for article (PubMed ID: 23590635)
1. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.
Knight S; Collins M; Takeuchi Y
Curr Gene Ther; 2013 Jun; 13(3):211-27. PubMed ID: 23590635
[TBL] [Abstract][Full Text] [Related]
2. Sola dosis facit venenum. Leukemia in gene therapy trials: a question of vectors, inserts and dosage?
Staal FJ; Pike-Overzet K; Ng YY; van Dongen JJ
Leukemia; 2008 Oct; 22(10):1849-52. PubMed ID: 18769449
[TBL] [Abstract][Full Text] [Related]
3. Review: Oncogenic Insertional Mutagenesis as a Consequence of Retroviral Gene Therapy for X-Linked Severe Combined Immunodeficiency Disease.
Ahmed B; Zafar M; Qadir MI
Crit Rev Eukaryot Gene Expr; 2019; 29(6):511-520. PubMed ID: 32422006
[TBL] [Abstract][Full Text] [Related]
4. Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones.
Bushman FD
Mol Ther; 2020 Feb; 28(2):352-356. PubMed ID: 31951833
[TBL] [Abstract][Full Text] [Related]
5. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.
Modlich U; Bohne J; Schmidt M; von Kalle C; Knöss S; Schambach A; Baum C
Blood; 2006 Oct; 108(8):2545-53. PubMed ID: 16825499
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of retroviral hematopoietic stem cell gene therapy.
Trobridge GD
Expert Opin Biol Ther; 2011 May; 11(5):581-93. PubMed ID: 21375467
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-induced oncogenesis and safety of retroviral vectors.
Nair V
Curr Opin Mol Ther; 2008 Oct; 10(5):431-8. PubMed ID: 18830918
[TBL] [Abstract][Full Text] [Related]
9. Reducing the genotoxic potential of retroviral vectors.
Ramezani A; Hawley TS; Hawley RG
Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646
[TBL] [Abstract][Full Text] [Related]
10. [Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].
Doi K; Takeuchi Y
Uirusu; 2015; 65(1):27-36. PubMed ID: 26923955
[TBL] [Abstract][Full Text] [Related]
11. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for severe combined immunodeficiencies and beyond.
Fischer A; Hacein-Bey-Abina S
J Exp Med; 2020 Jan; 217(2):. PubMed ID: 31826240
[TBL] [Abstract][Full Text] [Related]
13. Safety concerns related to hematopoietic stem cell gene transfer using retroviral vectors.
Haviernik P; Bunting KD
Curr Gene Ther; 2004 Sep; 4(3):263-76. PubMed ID: 15384940
[TBL] [Abstract][Full Text] [Related]
14. Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.
Fan H; Johnson C
Viruses; 2011 Apr; 3(4):398-422. PubMed ID: 21994739
[TBL] [Abstract][Full Text] [Related]
15. Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression.
Ginn SL; Liao SH; Dane AP; Hu M; Hyman J; Finnie JW; Zheng M; Cavazzana-Calvo M; Alexander SI; Thrasher AJ; Alexander IE
Mol Ther; 2010 May; 18(5):965-76. PubMed ID: 20354504
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vectors for gene therapy.
Maier P; von Kalle C; Laufs S
Future Microbiol; 2010 Oct; 5(10):1507-23. PubMed ID: 21073311
[TBL] [Abstract][Full Text] [Related]
17. Physiological promoters reduce the genotoxic risk of integrating gene vectors.
Zychlinski D; Schambach A; Modlich U; Maetzig T; Meyer J; Grassman E; Mishra A; Baum C
Mol Ther; 2008 Apr; 16(4):718-25. PubMed ID: 18334985
[TBL] [Abstract][Full Text] [Related]
18. Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation.
Kung HJ; Boerkoel C; Carter TH
Curr Top Microbiol Immunol; 1991; 171():1-25. PubMed ID: 1814689
[No Abstract] [Full Text] [Related]
19. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
Davé UP; Akagi K; Tripathi R; Cleveland SM; Thompson MA; Yi M; Stephens R; Downing JR; Jenkins NA; Copeland NG
PLoS Genet; 2009 May; 5(5):e1000491. PubMed ID: 19461887
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives.
Vargas JE; Chicaybam L; Stein RT; Tanuri A; Delgado-Cañedo A; Bonamino MH
J Transl Med; 2016 Oct; 14(1):288. PubMed ID: 27729044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
